Effects of glime piride and metformin on free fatty acid in patients with Type 2 diabetes mellitus

Journal of Central South University (Medical Sciences)

Volumn 29, Issue 6, 2004, Pages 631-634

  Tang, Jia Zhen ^a   Mao, Ji Ping ^a   Yang, Zhi Fang ^a   Zhou, Zhr Guang ^a   Tang, Wei Li ^a   Feng, Qiong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Free fatty acid; Glimepiride; Insulin resistance; Metformin; Type 2 diabetes mellitus

Indexed keywords

FATTY ACID; GLIMEPIRIDE; METFORMIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METFORMIN; MIDDLE AGED; SULFONYLUREA COMPOUNDS;

EID: 33846407602     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes[J]. Diabetes, 2002, 51(1):7-18.
2. Kabadi MU, Kabadi UM. Effects of glimepiride on insulin secretion and sensitivity in patients with recently diagnosed type 2 diabetes mellitus[J]. Clin Ther, 2004, 26(1):63-69. (Pubitemid 38241523)
3. Haffner SM, Gonzalez C, Miettinen H, et al. A prospective analysis of the HOMA model. The Mexico City Diabetes Study [J]. Diabetes Care, 1996, 19(10):1139-1141.
4. Abbasi F, Chu JW, McLaughlin T, et al. Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus[J]. Metabolism, 2004, 53(2):159-164. (Pubitemid 38168886)
5. Patane G, Piro S, Rabuazzo AM, et al. Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells[J]. Diabetes, 2000, 49(5):735-740. (Pubitemid 30339988)
6. Buse JB, Tan MH, Prince MJ, et al. The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes [J]. Diabetes Obes Metab, 2004, 6(2):133-156. (Pubitemid 38220106)
7. Lupi R, Dotta F, Marselli L, et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated [J]. Diabetes, 2002, 51(5):1437-1442. (Pubitemid 34826609)
8. Kabadi MU, Kabadi UM. Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus[J]. Ann Pharmacother, 2003, 37(11):1572-1576. (Pubitemid 37315093)
9. Bajaj M, Pratipanawatr T, Berria R, et al. Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes[J]. Diabetes, 2002, 51(10):3043-3048.
10. Kabadi MU, Kabadi UM. Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus[J]. Ann Pharmacother, 2003, 37(11):1572-1576. (Pubitemid 37315093)
11. Bajaj M, Pratipanawatr T, Berria R, et al. Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes[J]. Diabetes, 2002, 51(10):3043-3048.
12. Santomauro AT, Boden G, Silva ME, et al. Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and no n-diabetic subjects [J]. Diabetes, 1999, 48(9):1836-1841. (Pubitemid 29415205)